Companies: 10,795·Total market cap: $144.5T
Entia Biosciences, Inc.

Entia Biosciences, Inc.

ERGOOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$20197
P/E Ratio—
52W High$0.0402
52W Low$0.0001
Overview

Entia Biosciences, Inc. (ERGO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001408299 · ERGO · OTC · as of Jun 9, 2026

Filing snapshot

260
Total Filings
15-12G/A
Latest Form
2019-02-11
Most Recent
2008
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001408299 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2017-05-19
Fiscal Year End
May 19, 2017
Accession No.
0001185185-17-001225
Primary Document
entiabiosciences10k123116.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001408299 · Accession 0001185185-17-001225

Latest Key Filings

10-QQuarterly Report
10-Q
2016-11-14
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2018-09-07Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G/A15-12G/A
FORM 15-12G/A
2019-02-11
View
15-12G15-12G
FORM 15-12G
2018-12-19
View
8-KCurrent Report
FORM 8-K
2018-09-07
View
8-KCurrent Report
8-K
2018-04-20
View
8-KCurrent Report
8-K
2018-03-30
View
8-KCurrent Report
8-K
2017-12-04
View
CT ORDERCT ORDER
CT ORDER
2017-09-05
View
10-KAnnual Report
10-K
2017-05-19
View
NT 10-QNT 10-Q
NT 10-Q
2017-05-15
View
NT 10-KNT 10-K
NT 10-K
2017-03-31
View
DEF 14AProxy Statement
DEF 14A
2017-03-02
View
8-KCurrent Report
8-K
2017-02-24
View
PRE 14APRE 14A
PRE 14A
2017-02-17
View
8-KCurrent Report
8-K
2016-12-09
View
10-QQuarterly Report
10-Q
2016-11-14
View
Showing 1–15 of 210 filingsForm 4 / 144 hidden· 260 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001408299  |  Exchange: OTC · Healthcare

Entia Biosciences, Inc. (OTC: ERGO) has submitted 260 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2008. As a Healthcare sector company with CIK 0001408299, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Entia Biosciences, Inc.'s most comprehensive regulatory disclosure. The most recent Entia Biosciences, Inc. 10-K was filed on 2017-05-19 for fiscal year ending 2017. Historical ERGO 10-K annual reports are available from 2007 through 2017.

Investors researching Entia Biosciences, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
SAGD SEC Filings →DNAG SEC Filings →BTAX SEC Filings →STAB SEC Filings →REPCF SEC Filings →AVXT SEC Filings →WOWU SEC Filings →BTTX SEC Filings →
→ ERGO Financials→ ERGO Earnings→ ERGO Insider Trades

Frequently Asked Questions

ERGO SEC Filings · 8 questions

Entia Biosciences, Inc. (ERGO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 260 filings and access original documents at no cost. Entia Biosciences, Inc.'s CIK is 0001408299.

ERGO SEC filingsEntia Biosciences, Inc. SEC documentsfind ERGO 10-K